Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
33.83
+0.23 (0.68%)
At close: Apr 24, 2026

SHA:688139 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,5459,92411,11212,82420,07828,796
Market Cap Growth
-2.09%-10.69%-13.35%-36.13%-30.28%39.10%
Enterprise Value
9,5318,8459,53010,93517,32725,931
Last Close Price
33.8331.7834.6739.3961.0486.98
PE Ratio
42.2939.5830.3131.5833.4234.08
Forward PE
33.8319.6717.5318.5325.8739.80
PS Ratio
4.534.264.875.627.0113.55
PB Ratio
2.282.152.412.894.847.91
P/TBV Ratio
3.243.053.463.986.179.42
P/FCF Ratio
70.9566.7767.36177.9159.3774.39
P/OCF Ratio
39.3637.0438.1051.4531.7548.66
EV/Sales Ratio
4.093.804.174.796.0512.20
EV/EBITDA Ratio
30.8329.1222.5526.6327.6552.80
EV/EBIT Ratio
48.6945.1831.0834.9430.6958.67
EV/FCF Ratio
64.1259.5157.77151.7051.2466.99
Debt / Equity Ratio
0.010.010.010.000.010.00
Debt / EBITDA Ratio
0.100.100.050.040.040.01
Debt / FCF Ratio
0.200.200.140.250.080.02
Net Debt / Equity Ratio
-0.27-0.27-0.38-0.43-0.71-0.80
Net Debt / EBITDA Ratio
-4.15-4.15-4.15-4.63-4.71-5.90
Net Debt / FCF Ratio
-8.49-8.49-10.64-26.39-8.72-7.49
Asset Turnover
0.400.400.400.410.550.48
Inventory Turnover
3.673.674.094.534.843.58
Quick Ratio
1.611.612.092.272.682.69
Current Ratio
2.452.452.592.692.953.02
Return on Equity (ROE)
5.52%5.52%8.41%9.60%15.72%26.44%
Return on Assets (ROA)
2.11%2.11%3.39%3.55%6.79%6.25%
Return on Invested Capital (ROIC)
5.70%6.06%10.76%15.88%52.76%60.40%
Return on Capital Employed (ROCE)
4.20%4.20%6.40%6.80%13.10%11.80%
Earnings Yield
2.38%2.53%3.30%3.17%2.99%2.94%
FCF Yield
1.41%1.50%1.49%0.56%1.68%1.34%
Dividend Yield
0.98%1.04%1.36%1.31%0.74%0.57%
Payout Ratio
58.77%58.77%44.48%35.16%27.04%14.30%
Buyback Yield / Dilution
0.84%0.84%0.37%0.20%-0.06%2.43%
Total Shareholder Return
1.83%1.88%1.73%1.51%0.68%3.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.